The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1589
January 13, 2020
View Complete Issue         Table of Contents 2019 
Antiviral Drugs for Influenza
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Antiviral Drugs for Influenza
January 13, 2020 (Issue: 1589)
Influenza is generally a self-limited illness, but pneumonia, respiratory failure, and death can occur. FDA-approved antiviral drugs for influenza are listed in Table 2. The neuraminidase inhibitors oseltamivir (Tamiflu, and generics), which is...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Antiviral Drugs for Influenza
Article code: 1589a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.